Search by Drug Name or NDC
NDC 42291-0778-90 Silodosin 8 mg/1 Details
Silodosin 8 mg/1
Silodosin is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is SILODOSIN.
MedlinePlus Drug Summary
Silodosin is used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia; BPH), which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying), painful urination, and urinary frequency and urgency. Silodosin is in a class of medications called alpha-blockers. It relieves the symptoms of BPH by relaxing the muscles of the bladder and prostate.
Related Packages: 42291-0778-90Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Silodosin
Product Information
| NDC | 42291-0778 |
|---|---|
| Product ID | 42291-778_0e9abeed-2337-d18a-e063-6394a90a4127 |
| Associated GPIs | |
| GCN Sequence Number | 064847 |
| GCN Sequence Number Description | silodosin CAPSULE 8 MG ORAL |
| HIC3 | Q9B |
| HIC3 Description | BENIGN PROSTATIC HYPERTROPHY/MICTURITION AGENTS |
| GCN | 16858 |
| HICL Sequence Number | 036119 |
| HICL Sequence Number Description | SILODOSIN |
| Brand/Generic | Generic |
| Proprietary Name | Silodosin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Silodosin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 8 |
| Active Ingredient Units | mg/1 |
| Substance Name | SILODOSIN |
| Labeler Name | AvKARE |
| Pharmaceutical Class | Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209745 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 42291-0778-90 (42291077890)
| NDC Package Code | 42291-778-90 |
|---|---|
| Billing NDC | 42291077890 |
| Package | 90 CAPSULE in 1 BOTTLE (42291-778-90) |
| Marketing Start Date | 2022-10-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |